Melia, Michael T <br/><br/>
Racial differences in hepatitis C treatment eligibility.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jul 2011 
 - 70-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.24358  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alcoholism--complications<br/>Antiviral Agents--therapeutic use<br/>Black People<br/>Diabetes Complications<br/>Eligibility Determination--trends<br/>Female<br/>Heart Diseases--complications<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Mass Screening--methods<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins<br/>Renal Insufficiency--complications<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Substance-Related Disorders--complications<br/>Treatment Outcome<br/>United States<br/>White People<br/>Black or African American